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Abstract: Toxoplasma gondii (T. gondii) is a microscopic, apicomplexan parasite that can infect muscle
or neural tissue, including the brain, in humans. While T. gondii infection has been associated with
changes in mood, behavior, and cognition, the mechanism remains unclear. Recent evidence suggests
that T. gondii may harvest folate from host neural cells. Reduced folate availability is associated
with an increased risk of neurodevelopmental disorders, neurodegenerative diseases, and cognitive
decline. We hypothesized that impairment in cognitive functioning in subjects seropositive for
T. gondii might be associated with a reduction of folate availability in neural cells. We analyzed data
from the third National Health and Nutrition Examination Survey to determine the associations
between T. gondii infection, multiple folate-cycle factors, and three tests of cognitive functioning
in U.S. adults aged 20 to 59 years. In these analyses, T. gondii moderated the associations of folate,
vitamin B-12, and homocysteine with performance on the Serial Digit Learning task, a measure of
learning and memory, as well as the association of folate with reaction time. The results of this
study suggest that T. gondii might affect brain levels of folate and/or vitamin B-12 enough to affect
cognitive functioning.
Keywords: Toxoplasma gondii; Folate; Cognition; Memory; Vitamin B-12; Homocysteine

1. Introduction
Toxoplasma gondii (T. gondii) is an apicomplexan parasite that infects approximately 12% of the
U.S. population as of 2010 [1]. Although the parasite’s definitive host is any member of the cat family,
humans can become infected with T. gondii as an intermediate host via ingestion of contaminated foods
or by exposure to cat feces [2]. Upon successful invasion, T. gondii infects muscle and neural tissue
and encapsulates itself in a cyst that protects it against the host immune system [3]. T. gondii biology
has unique features that set it apart from other intracellular parasites. For example, using precursors
from the infected cell, T. gondii can synthesize dopamine [4,5], although the physiological effects of this
dopamine production remain unknown.
Beyond dopamine production, T. gondii may influence other aspects of host biology. In regards
to folate synthesis, T. gondii may salvage or harvest folate directly from the infected host cell [6].
It is unknown, however, whether this might affect host health. Further, it is unclear whether T. gondii
depends on the folate acquired from the host or if the system is only supplementary.
In humans, folate is essential for DNA synthesis and repair and is a key factor in cell division
and growth [7]. The brain requires a constant supply of dietary folate for early embryonic
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ortho-phenylene diamine resulting in a color change proportional to the total T. gondii antibody
concentration in the sample. The color change is read as an optical density via spectrophotometer and
compared to a standard curve calibrated to World Health Organization Toxo 60 serum. Possible IgG
titer values ranged from 0 IU/mL to 240 IU/mL (higher concentrations were collapsed to 240 IU/mL
to reduce the risk of deductive disclosure). Subjects with titer values above 7 IU/mL were considered
seropositive for T. gondii exposure, whereas subjects below this level were considered negative [17].
Anti-T. gondii IgG antibodies indicate past exposure to T. gondii. Further, IgG titer levels can vary across
the lifespan potentially due to multiple exposures or natural anamnestic decreases in IgG levels [18–20].
However, the procedures and classification system used in the NHANES III remain the industry norm
(excepting minor differences in the IgG titer cut-off point for seropositivity depending on the specific
assay/manufacturer) in identifying individuals exposed to and likely infected with T. gondii.
2.3. B-Vitamin Biomarkers
Serum concentrations of folate and vitamin B-12 were determined by CDC laboratory technicians
using a Quantaphase Folate radioassay kit from Bio-Rad Laboratories. The Quantaphase Folate
radioassay kit contains a detailed description of the methods used to prepare the folate and B-12
samples [21]. Following sample preparation, concentration is calculated from a standard curve.
Serum homocysteine concentration was determined via reverse-phase, high-performance liquid
chromatography and fluorescence detection as described in the NHANES III laboratory manual [17].
Importantly, data for the NHANES III was collected before the introduction of mandatory folic acid
food fortification [22]. Therefore, reported average serum concentrations of folate and/or vitamin B-12
for subjects surveyed in the NHANES III may be lower than more recent averages.
2.4. Cognitive Functioning
In the NHANES III, computerized versions of the Symbol Digit Substitution (SDS), Serial Digit
Learning (SDL), and Reaction Time (RT) tests assessed general cognitive function. In the SDS, subjects
were required to match a series of symbols with their respective digits using a key given at the top of
the computer screen for four trials. Each trial consisted of nine digit-symbol pairings, and the total
latency (in seconds) for each of the nine possible symbol-digit pairings was recorded for each trial.
Finally, the average of the two lowest total latencies from the four trials was used as the final score.
Therefore, a lower score, or faster pairing, on the SDS indicates better performance. The SDL required
subjects to memorize and recall a series of eight random digits over eight trials. Scores on the SDL
reflected the number of errors made in each trial. Therefore, a lower score, or fewer errors, indicates
better performance on the SDL. Subjects who successfully repeated the eight-digit sequence for two
consecutive trials were not required to complete the remaining trials. Finally, RT was measured by
pressing a button as quickly as possible whenever a square appeared in the center of the computer
screen. The average RT (in milliseconds (ms)) over 50 trials was used as the final score with faster
times indicating better RT performance. Krieg et al. [23] provides a detailed description of the three
cognitive tests used in the NHANES III.
2.5. Covariates
We included a number of covariates in all analyses to control for potential confounding.
Continuous covariates included age in years, poverty-to-income ratio (PIR), and years of education.
PIR is a measure of an individual’s socioeconomic status computed by dividing the household income
by the federal poverty level (at the time of the survey) resulting in a minimum value of zero and a
maximum of five (higher values were collapsed to five to reduce the risk of deductive disclosure).
Categorical variables included sex and race-ethnicity. For the race-ethnicity variable, the NHANES III
survey asked all participants to self-report one of the following race-ethnicity categories: non-Hispanic
white, non-Hispanic black, Mexican American, or “other”.
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2.6. Statistical Analysis
We used Stata 14.2 [24] for all statistical analyses. We computed summary statistics for all
variables included in our analyses and computed means and standard errors for continuous variables
and proportions and standard errors for categorical variables. Ordinary least squares regression was
used to test for differences between T. gondii seropositive and seronegative subjects on each of the
variables included in this study. Only the p-values for these comparisons are reported in Table 1. We
used ordinary least squares regression to test for interaction effects between T. gondii seropositivity and
folate, vitamin B-12, or homocysteine concentrations in the prediction of SDS, SDL, or RT scores for a
total of nine separate models. We included age, PIR, education, sex, and race-ethnicity as covariates in
each model.
For each analysis, we report main effects for T. gondii, a folate-cycle factor, and their interaction.
The coefficient for T. gondii is the score on the respective cognitive test for subjects seropositive for
T. gondii infection. The coefficient for the folate-cycle factors represents the relationship between
each factor and scores on each of the three cognitive tests for subjects who were seronegative for
T. gondii infection. The interaction of folate-cycle factors and T. gondii is the change in the slope of the
folate-cycle factor for those subjects seropositive for T. gondii relative to those seronegative for T. gondii.
Table 1. Weighted summary statistics of U.S. adults 20 to 59 year olds, National Health and Nutrition
Examination Survey III 1988–1994.
T. Gondii
Seropositive
N = 417
Sociodemographic Factors
Age (years)
Poverty-to-income Ratio
Education (years)
Female
Race-ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other
Biochemistry
Folate (ng/mL)
Vitamin B-12 (pg/mL)
Homocysteine (umol/L)
Cognitive Testing
Symbol Digit Substitution Score
Serial Digit Learning Score
Reaction Time (sec)

T. Gondii
Seronegative
N = 1620

Mean or Frequency

SE

Mean or Frequency

SE

p

41.54
3.23
12.36
45.63%

1.01
0.25
0.23
2.65%

36.16
3.38
13.13
51.55%

0.63
0.13
0.12
1.08%

<0.001
0.316
<0.001
0.050

72.73%
10.77%
5.87%
10.62%

3.92%
1.64%
0.81%
3.25%

77.98%
10.55%
5.50%
5.97%

1.27%
0.47%
0.40%
1.14%

0.159
0.896
0.691
0.097

7.08
521.83
9.36

0.51
44.25
0.27

6.89
474.01
9.56

0.24
7.08
0.25

0.807
0.623
0.282

2.85
5.45
240.1

0.05
0.31
3.03

2.55
3.91
234.47

0.03
0.15
1.71

<0.001
<0.001
0.070

Abbreviations: SE = Standard Error.

3. Results
Of the 2037 subjects included in this study, approximately 20% were seropositive for T. gondii,
50% were female, and approximately 75% were non-Hispanic white. Table 1 presents these and other
demographic and study-sample characteristics.
We found no significant interactions between T. gondii seropositivity and any of the folate-cycle
factors in predicting performance on the SDS. In predicting performance on the SDL, T. gondii
seropositivity interacted with folate (β = −1.02, (95% CI: −1.88, –0.16), p = 0.021; Table 2), vitamin
B-12 (β = −1.60, (95% CI: −2.98, −0.23), p = 0.023; Table 3), and homocysteine concentrations
(β = 2.40, (95% CI: 0.94, 3.85), p = 0.002; Table 4) (Figure 2). In subjects seronegative for T. gondii, SDL
performance was relatively constant as folate, vitamin B-12 or homocysteine levels varied. However,
in subjects seropositive for T. gondii, performance on the SDL worsened as folate and vitamin B-12
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levels decreased and as homocysteine levels increased (Figure 2). An interaction between T. gondii
seropositivity and folate concentration predicted RT (β = 14.88, (95% CI: 5.99, 23.76), p = 0.001; Table 2).
In contrast to the SDL, subjects seropositive for T. gondii performed better on the RT assessment as
folate concentration decreased.
Table 2. Two-way interaction effects of serum folate concentration and Toxoplasma gondii infection
status predicting SDS, SDL, and RT cognitive assessment scores for U.S. 20 to 59 year olds.
Symbol Digit Substitution
Folate
T. gondii
T. gondii × Folate
Interaction
Race-Ethnicity
Non-Hispanic White (ref)
Non-Hispanic Black
Mexican American
Other
Female
Age (years)
PIR
Education (years)
Constant

Serial Digit Learning

Reaction Time

β
0.01
0.15

95% CI
(−0.04, 0.05)
(−0.08, 0.38)

p
0.786
0.185

β
0.10
2.48

95% CI
(−0.33, 0.53)
(1.02, 3.94)

p
0.641
0.001

β
−1.19
−20.60

95% CI
(−5.55, 3.16)
(−34.38, −6.83)

p
0.585
0.004

−0.07

(−0.20, 0.07)

0.344

−1.13

(−1.97, −0.29)

0.009

13.07

(4.20, 21.93)

0.005

0.30
0.27
0.29
−0.17
0.03
−0.03
−0.10
2.91

(0.21, 0.39)
(0.18, 0.37)
(0.10, 0.47)
(−0.24, −0.10)
(0.03, 0.03)
(−0.04, −0.02)
(−0.11, −0.08)
(2.70, 3.12)

<0.001
<0.001
0.003
<0.001
<0.001
<0.001
<0.001
<0.001

1.72
2.52
1.88
0.08
0.09
−0.25
−0.46
6.77

(1.15, 2.29)
(1.95, 3.09)
(0.69, 3.08)
(−0.23, 0.38)
(0.07, 0.11)
(−0.35, −0.14)
(−0.57, −0.35)
(4.96, 8.57)

<0.001
<0.001
0.003
0.611
<0.001
<0.001
<0.001
<0.001

5.92
1.23
−4.15
8.63
0.36
−3.13
−2.93
267.68

(0.14, 11.70)
(−6.86, 9.32)
(−14.36, 6.06)
(1.60, 15.66)
(0.14, 0.58)
(−4.33, −1.92)
(−4.08, −1.79)
(250.01, 285.34)

0.045
0.761
0.418
0.017
0.002
<0.001
<0.001
<0.001

Notes: Age, sex, education, race-ethnicity, and poverty-to-income ratio included as controls in all models.
Abbreviations: SDS, the Symbol Digit Substitution; SDL, Serial Digit Learning; RT, Reaction Time; CI = Confidence
Interval; ref = Reference category; PIR, poverty-to-income ratio. N = 2037.

Table 3. Two-way interaction effects of serum vitamin B-12 concentration and Toxoplasma gondii
infection status predicting SDS, SDL, and RT cognitive assessment scores for U.S. 20 to 59 year olds.
Symbol Digit Substitution
Vitamin B-12
T. gondii
T. gondii Vitamin B-12
Interaction
Race-Ethnicity
Non-Hispanic White (ref)
Non-Hispanic Black
Mexican American
Other
Female
Age (years)
PIR
Education (years)
Constant

Serial Digit Learning

Reaction Time

β
0.05
1.06

95% CI
(−0.00, 0.11)
(−0.12, 2.25)

p
0.057
0.076

β
0.23
10.24

95% CI
(−0.26, 0.72)
(2.14, 18.33)

p
0.346
0.014

β
−3.04
5.26

95% CI
(−8.77, 2.68)
(−123.23, 133.74)

p
0.291
0.935

−0.17

(−0.36, 0.03)

0.087

−1.59

(−2.92, −0.26)

0.020

−0.61

(−21.40, 20.19)

0.954

0.30
0.27
0.29
−0.17
0.03
−0.03
−0.10
2.61

(0.21, 0.39)
(0.18, 0.37)
(0.10, 0.47)
(−0.24, −0.10)
(0.03, 0.03)
(−004, −0.02)
(−0.11, −0.08)
(2.22, 2.99)

<0.001
<0.001
0.003
<0.001
<0.001
<0.001
<0.001
<0.001

1.78
2.53
1.87
0.08
0.09
−0.24
−0.47
5.68

(1.19, 2.37)
(1.96, 3.10)
(0.67, 3.08)
(−0.21, 0.36)
(0.07, 0.11)
(−0.34, −0.14)
(−0.58, −0.35)
(2.42, 8.93)

<0.001
<0.001
0.003
0.583
<0.001
<0.001
<0.001
0.001

6.09
1.81
−4.59
8.52
0.40
−3.14
−2.83
281.51

(0.18, 12.01)
(−6.22, 9.84)
(−14.98, 5.81)
(1.64, 15.40)
(0.17, 0.63)
(−4.32, −1.97)
(−4.03, −1.64)
(239.25, 323.77)

0.044
0.653
0.380
0.016
0.001
<0.001
<0.001
<0.001

Notes: Age, sex, education, race-ethnicity, and poverty-to-income ratio included as controls in all models.
Abbreviations: CI = Confidence Interval, ref = Reference category. N = 2037.

Table 4. Two-way interaction effects of serum homocysteine concentration and Toxoplasma gondii
infection status predicting SDS, SDL, and RT cognitive assessment scores for U.S. 20 to 59 year olds.
Symbol Digit Substitution
Homocysteine
T. gondii
T. gondii × Homocysteine
Interaction
Race-Ethnicity
Non-Hispanic White (ref)
Non-Hispanic Black
Mexican American
Other
Female
Age (years)
PIR
Education (years)
Constant

Serial Digit Learning

Reaction Time

β
−0.05
−0.35

95% CI
(−0.13, 0.02)
(−1.17, 0.48)

p
0.166
0.403

β
−0.59
−4.87

95% CI
(−1.22, 0.03)
(−7.88, −1.85)

p
0.060
0.002

β
−2.72
−10.87

95% CI
(−9.05, 3.62)
(−45.43, 23.70)

p
0.393
0.531

0.18

(−0.20, 0.56)

0.351

2.49

(1.09, 3.89)

0.001

5.67

(−11.10, 22.43)

0.501

0.31
0.27
0.29
−0.18
0.03
-0.03
-0.10
3.04

(0.22, 0.40)
(0.17, 0.37)
(0.11, 0.48)
(−0.25, −0.10)
(0.03, 0.03)
(−0.05, −0.02)
(−0.11, −0.08)
(2.78, 3.30)

<0.001
<0.001
0.002
<0.001
<0.001
<0.001
<0.001
<0.001

1.79
2.52
1.98
0.02
0.09
−0.25
−0.47
8.36

(1.19, 2.38)
(1.96, 3.08)
(0.81, 3.15)
(−0.31, 0.34)
(0.07, 0.11)
(−0.35, −0.15)
(−0.59, −0.36)
(6.08, 10.65)

<0.001
<0.001
0.001
0.926
<0.001
<0.001
<0.001
<0.001

5.50
1.41
−3.92
8.13
0.42
−3.21
−2.83
268.43

(−0.33, 11.34)
(−6.81, 9.62)
(−13.95, 6.11)
(1.12, 15.13)
(0.18, 0.66)
(−4.45, −1.98)
(−4.02, −1.64)
(243.08, 293.78)

0.064
0.732
0.436
0.024
0.001
<0.001
<0.001
<0.001

Notes: Age, sex, education, race-ethnicity, and poverty-to-income ratio included as controls in all models.
Abbreviations: CI = Confidence Interval, ref = Reference category. N = 2037.
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Figure 2. Significant interaction between folate-cycle factors and Toxoplasma gondii predicting cognitive
Figure 2. Significant interaction between folate‐cycle factors and Toxoplasma gondii predicting
performance in U.S. adults. Notes: Higher values on each cognitive assessment indicate worse
cognitive performance in U.S. adults. Notes: Higher values on each cognitive assessment indicate
performance. Values for folate, vitamin B-12, and homocysteine were logarithmically transformed.
worse performance. Values for folate, vitamin B‐12, and homocysteine were logarithmically
transformed.
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Purines synthesized during folate metabolism contribute to the biosynthesis of guanosine triphosphate
(GTP), a precursor of tetrahydrobiopterin (BH4 ). Tyrosine hydroxylase and tryptophan hydroxylase
each utilize BH4 as a co-factor in the production of dopamine and serotonin, respectively. Therefore,
reduced availability of dietary folate may indirectly lead to an overall decrease of dopamine and
serotonin production [9,33]. In the case of T. gondii seropositivity, the combined effects of low
concentrations of folate and simultaneous folate harvesting from T. gondii might particularly affect
infected neural cells. Since dopamine and serotonin both influence various cognitive functions such
as memory, attention, and executive function [34–36], this link could potentially offer an alternate
explanation of the effects observed in this study.
Beyond performance on the SDL, there was a significant interaction between T. gondii and
folate concentration in the prediction of RT. However, the direction of the observed relationship
suggested that T. gondii seropositivity might actually be favorable in regards to RT in cases of low folate
concentration and detrimental in cases of high folate concentration. Though not statistically significant,
we found a similar relationship in a previous study [37] exploring interactions between the bacterium
Helicobacter pylori and folate concentration in the prediction of RT. Similar to T. gondii, Helicobacter pylori
might also reduce folate availability [38], though by a different mechanism. Despite these differing
mechanisms of folate reduction, in both cases, RT improved, suggesting that folate deficiency associated
with T. gondii might enable some advantage in RT. We are unaware of a mechanism that might explain
how reductions in folate availability by infectious diseases such as T. gondii or Helicobacter pylori could
be favorable towards RT performance. The data available in the NHANES III do not allow for an
in-depth exploration of this association. Future research into this finding would likely require animal
models or neuroimaging combined with biochemical testing to determine how regions of the brain
active during RT tasks might be affected by reductions in folate availability.
Some limitations require consideration when interpreting the results of this study. The NHANES data
sets are cross-sectional in design and thus preclude the ability to make casual inferences. Further, as the
degree to which T. gondii harvests folate from infected host cells is not clear, it is currently unknown whether
T. gondii harvests enough to affect cognitive functioning. With these data, it is also impossible to determine
the time of initial infection by T. gondii or the frequency with which individuals have encountered the
parasite in their lifetime. It is possible that the effects of T. gondii on folate availability and on cognition
could vary based on the length of infection with the parasite or based on the number of exposures to the
parasite. Finally, folate and vitamin B-12 availability can vary for a multitude of reasons including genetic
mutations in key folate-cycle enzymes [7,39,40]. Although the NHANES III does include genetic data,
access to the data is restricted and requires funding to obtain it. Therefore, additional research is needed to
identify other factors that might modify the effects observed in this study.
This study is strengthened by using multiple controls that limit the number of potential confounds that
might explain the observed effects. Specifically, by controlling for demographic and other health factors,
we were more confident that the interactions between T. gondii and concentrations of folate, vitamin B-12,
or homocysteine were associated with the variation in SDL or RT scores. Finally, use of the NHANES III
data sets resulted in a large sample size that increases the generalizability of the findings and study power.
This study consisting of 2037 U.S. adults presents evidence of an interaction effect between
T. gondii seropositivity and concentrations of multiple folate-cycle factors on cognitive functioning in
adult humans. Additional research is recommended to explore the specific mechanisms involved in
this association and to determine any additional potential consequences to folate and/or vitamin B-12
availability following T. gondii infection.
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